Your briefing

Intensity Therapeutics, Inc. Announces that INT230-6 Achieved 100% Complete Response Rate in Preclinical Models of Malignant Peripheral Nerve Sheath Tumors (MPNST)
2 US firefighters killed in sniper-style ambush in Idaho
Iran acknowledges death toll from Israel's strike on notorious Evin prison